The Problems Of Physician-Scientists

Are the difficulties of doing both clinical and basic research hampering the progress of medical science? Sir David Weatherall is a worried man. When the Muffield professor of Medicine at Oxford University gazes out at the unsolved problems of medical science, he sees deadly diseases like cancer and circulatory problems still killing people by the millions around the world. And he fears that the diseases may remain scourges because of a failing of the scientific community. "The reason that we

Written byRichard Smith
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The Oxford don is not alone in his worries. In Britain especially there is anxiety about shortages of scientists who can do both basic and clinical research. The fears have prompted a number of new programs designed to train students in both areas. But even as a new generation of researchers with M.D.'s and Ph.D.'s begins to emerge, many scientists are wondering if it really is still possible to straddle the two worlds. As Norman Kreitman, a psychiatrist and director of a research unit in Edinburgh, says: "It's becoming more and more difficult to be both a clinician and a scientist because both jobs are becoming ever more specialized and complex."

The shortage of physician-scientists is difficult to measure. But all of the researchers contacted by The Scientist agreed that it has the potential for slowing the pace of biomedical research. Steve Reeders, a scientist and physician working at Yale ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies